Value Bridge — UC DAVIS MEDICAL CENTER
Current $-377M → Target $-304M (+$72.4M)
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-376.6M
Current EBITDA
$-304.1M
Target EBITDA
+$72.4M
Total Uplift
7
Value Levers
EBITDA Bridge — 7 Lever Model
Each lever shows gross impact, probability of achievement, and probability-weighted value.
Denial Rate Reduction
$0.0M
AR Acceleration
$0.0M
Coding Accuracy Uplift
$16.4M
Payer Mix Optimization
$39.3M
Cost to Collect Reduction
$13.1M
Clean Claim Improvement
$9.8M
Volume & Rate Growth
$65.5M
What This Means
The 7-lever model projects a 0% EBITDA uplift from $-377M to $-304M. The highest-impact lever is Volume & Rate Growth at $26.2M probability-weighted.
IC talking point: "We see $72M in annual EBITDA improvement, primarily from volume & rate growth. At an 11x multiple, this represents $797M in equity value creation."